Literature DB >> 30060033

Association between miRNA-146a and Polymorphisms of its Target Gene, IRAK1, Regarding Susceptibility to and Clinical Features of Systemic Lupus Erythematous and Multiple Sclerosis.

Dalia A Labib1, Olfat G Shaker2, Rasha M El Refai3, Shada A Ghoniem3, Alaa Elmazny4.   

Abstract

Single-nucleotide polymorphisms (SNPs) in microRNA-146a (miRNA-146a) can be associated with the development of immune-system dysfunctions.The aim of this work is to correlate SNPs of miRNA-146a and its target gene, IRAK1, with susceptibility, clinical manifestations, and diseases progression in patients with systemic lupus erythematous (SLE) and multiple sclerosis (MS). Genotyping for miRNA-146a (rs2910164) and its target gene IRAK1 (rs3027898) was performed using real-time polymerase chain reaction (RT-PCR) in 80 patients with SLE and 70 patients with MS, as well as 120 healthy control individuals. A statistically significant difference was found between the frequencies of the genotypes and alleles of miRNA-146a (rs2910164) and IRAK1 (rs3027898), compared with the control group. Also, whereas the mutant allele G of miRNA-146a may be a factor in the pathogenesis of lupus nephritis, the mutant allele C of IRAK1 may play a role in lupus arthritis. Both genes may contribute to the susceptibility of patients to SLE and MS.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30060033     DOI: 10.1093/labmed/lmy033

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  8 in total

1.  mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations.

Authors:  Basima A El-Akhras; Yasser B M Ali; Samir A El-Masry; Iman H Bassyouni; Ibrahim H El-Sayed; Roba M Talaat
Journal:  Noncoding RNA Res       Date:  2022-05-26

2.  Meta-analysis of association of microRNAs genetic variants with susceptibility to rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Fengzhen Liu; Yahang Liang; Yu Zhao; Lili Chen; Xiaolin Wang; Chunquan Zhang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

3.  Association between risk of brucellosis and genetic variations in MicroRNA-146a.

Authors:  Sima Kazemi; Saeid Afshar; Manoochehr Karami; Massoud Saidijam; Fariba Keramat; Seyed Hamid Hashemi; Mohammad Yousef Alikhani
Journal:  BMC Infect Dis       Date:  2021-10-16       Impact factor: 3.090

4.  Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease.

Authors:  Jun Zhang; Handan Tan; Qingfeng Cao; Guannan Su; Peizeng Yang
Journal:  Dis Markers       Date:  2021-10-08       Impact factor: 3.434

5.  Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractants.

Authors:  Thomas Hoyler; Bettina Bannert; Cédric André; Damian Beck; Thomas Boulay; David Buffet; Nadja Caesar; Thomas Calzascia; Janet Dawson; Diego Kyburz; Robert Hennze; Christine Huppertz; Amanda Littlewood-Evans; Pius Loetscher; Kirsten D Mertz; Satoru Niwa; Gautier Robert; James S Rush; Giulia Ruzzante; Sophie Sarret; Thomas Stein; Ismahane Touil; Grazyna Wieczorek; Geraldine Zipfel; Stuart Hawtin; Tobias Junt
Journal:  JCI Insight       Date:  2022-07-08

6.  The Analysis of SNPs' Function in miR-21 and miR146a/b in Multiple Sclerosis and Active Lesions: An In Silico Study.

Authors:  Mahta Moraghebi; Ahmad Agha Negahi; Homa Bazireh; Hossein Abbasi; Mohsen Ahmadi; Zohreh Sarikhani; Pegah Mousavi
Journal:  Bioinform Biol Insights       Date:  2022-08-04

Review 7.  Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World.

Authors:  Nicoletta Nuzziello; Loredana Ciaccia; Maria Liguori
Journal:  Cells       Date:  2019-12-27       Impact factor: 6.600

Review 8.  Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.

Authors:  Chunjuan Yang; Jianmei Sun; Yipeng Tian; Haibo Li; Lili Zhang; Jinghan Yang; Jinghua Wang; Jiaojiao Zhang; Shushan Yan; Donghua Xu
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.